PDF 805 KB
Clinical Guideline developed to guide the management of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP)
Healthcare associated infections are a major cause of poor outcomes for patients. Ventilator associated-pneumonia (VAP), a subset of hospital acquired pneumonia, results in increased patient morbidity and mortality, prolonged length of stay and increased healthcare costs. VAP can occur in up to 25% of all people who require mechanical ventilation.
VAP can be caused by the migration of microorganisms from colonised endotracheal and/or tracheostomy tubes, direct inoculation via bronchoscopy or other respiratory procedures or by aspiration. Affected patients may have prior underlying lung disease or immune suppression.
Intubation and tracheostomy tube insertion should only be undertaken by persons trained and competent in the technique.
It is a SA Health requirement that SA Health healthcare facilities are compliant with the Australian Commission on Safety and Quality in Health Care (ACSQHC) National Safety and Quality Health Service (NSQHS). This includes the safe insertion and management of invasive medical devices.
For further information refer to:
The Australian Guidelines for the Prevention and Control of Infection in Healthcare which also includes VAP associated care bundles.